back to homepage
ABSTRACTS SCIENTIFIC
PROGRAMME
REGISTRATION ACCOMMODATION

PROGRAMME AT A GLANCE

PROGRAMME IN DETAILS

SCOPE SCHOOL

4TH MOOS

INSTRUCTIONS FOR ORAL PRESENTATION

INSTRUCTIONS FOR POSTER PRESENTATION

INSTRUCTIONS FOR VIDEO PRESENTATION

Scientific Programme in Details

 

 

 

 

 

Wednesday, May 16

  MC3
08.30-17:00 WORLD OBESITY FEDERATION:  SCOPE SCHOOL ATHENS
  Conference Room 1
15:00-18:30 4TH MEDITERRANEAN OBESITY SURGERY SUMMIT (MOSS)
   
18:00 Exhibition and Registration Opening
   
19:00 Welcome Reception

 

Thursday, May 17

  Nikos Skalkotas Hall
09:00-10:30 OPENING SESSION NAFLD/NASH
Chairs Michel Suter, Harry Pappis
09:00-09:10 Welcome speech
  Michel Suter (Switzerland); Harry Pappis (Greece)
09:10-09:40 Plenary lecture: Treating NASH with metabolic surgery?
  François Pattou (France)
09:0-10:00 Lifestyle intervention for NAFLD/NASH
  Alexander Kokkinos (Greece)
10:00-10:20 GLP-1 receptor analogues and NAFLD/NASH
  Carel Le Roux (Ireland)
10:20-10:30 Discussion
   
  MC2
09:40-10:30 ORAL COMMUNICATIONS: Surgical Complications
Chairs Gerhard Prager, Scott Shikora, Dimitris Zacharoulis
09:40-10:00 Introductory: When things go wrong - why patients go to lawyers
  Alberic Fiennes (UK)
10:00-10:10 O-001 Fast track surgery program (FTS) in bariatric surgery, Is it safe? (ID 235)
  Abdelrahman M Galal (The Netherlands)
10:10-10:20 O-002 Bariatric surgery related complications during pregnancy (ID 102)
  Martine Uittenbogaart (The Netherlands)
10:20-10:30 O-003 Trocar site hernia in bariatric surgery- an underestimated problem. A qualitative systematic review (ID 115)
  Ioannis Karampinis (Germany)
   
  MC3
09:40-10:30 ORAL COMMUNICATIONS: Metabolic Mechanisms of Surgeries
Chairs Rachel Batterham, Juan Pujol Rafols, John Melissas
09:40-09:50 O-004 Tailored Laparoscopic OAGB as an anti-diabetic procedure in BMI (30-35) (ID 111)
  Ahmed Elsobky (Egypt)
09:50-10:00 O-005 Shortening the biliopancreatic limb length could prevent undernutrition risk while maintaining glucose homeostasis improvement: demonstration in a rat model of One Anastomosis Gastric Bypass (ID 101)
  Maude Le Gall (France)
10:00-10:10 O-006 Incidence of secondary hyperparathyroidism after biliopancreatic diversion with duodenal switch for morbid obesity: an underestimated phenomenon (ID 204)
  Philipp C. Nett (Switzerland)
10:10-10:20 O-007 The impact of bariatric surgery on gut microbiota, diabetes remission and metabolic profile of morbidly obese patients: a comprehensive meta-analysis (ID 55)
  Dimitrios Magouliotis (Greece)
10:20-10:30 O-008 Somatotropic axis (GH/ IGF-1) variations after bariatric surgery in morbidly obese nondiabetic patients (ID 185)
  Maria E. Barmpari (Greece)
   
10:30-11:00 POSTER SESSION I / COFFEE BREAK / COMMERCIAL EXHIBITION
   
  Nikos Skalkotas Hall
11:00-12:30 BARIATRIC SURGERY AT THE EXTREMES
Chairs Ralph Peterli, Francois Pattou, George Stavropoulos
11:00-11:20 Place of bariatric/metabolic surgery in adolescents
  Torsten Olbers (Sweden)
11:20-11:40 Is there a role for bariatric/metabolic surgery in patients over 65 yeras of age?
  Pierre Fournier (Switzerland)
11:40-12:00 What is the role of bariatric/metabolic surgrey before or after transplantation?
  Antonio Iannelli (France)
12:00-12:20 Bariatric surgery and psychiatric disorders: Where are the limits?
  Fausta Micanti (Italy)
12:20-12:30 Discussion
   
  MC2
11:00-12:30 GREEK  SESSION: Surgical Treatment of Diabetes Type II, Multidisciplinary Approach
Chairs Alberic  Fiennes, Carl le Roux, Nikolaos Tentolouris
11:00-11:15 Metabolic surgery v conventional medical treatment. Overview of RCT’s
  George Skroubis (Greece)
11:15-11:30 Definition of diabetes-specific goals and success of surgical treatment
  Georgios Valsamaki (Greece)
11:30-11:45 What are the limits of the medical treatment of T2DM? When would I refer a patient for surgery?
  Vaia Lambadiari (Greece)
11:45-12:00 It’s all about Incretins, or there is more in the T2DM improvement after metabolic surgery?
  Theodoros Alexandridis (Greece)
12:00-12:15 The role of gut microbiota and bile acids in the effects of bariatric/metabolic surgery on obesity and T2DM
  Emmanouil Papadakis (Greece)
12:15-12:30 Short- and long-term safety of metabolic surgery procedures
  Andreas Alexandrou (Greece)
   
  MC3
11:00-12:30 ORAL COMMUNICATIONS: Results of Bariatric Surgeries
Chairs Edo Aarts, Nikolaos Georgopoulos
11:00-11:10 O-009 Omega Loop Gastric Bypass two years follow up –weight loss, early and late complications (ID 74)
  Eliezer Avinoah (Israel)
11:10-11:20 O-010 Banded versus non-banded Roux-en-Y Gastric Bypass for morbid obesity: A meta-analysis (ID 112)
  Dimitrios Magouliotis (Greece)
11:20-11:30 O-011 Outcomes 15 years and beyond following adjustable gastric banding for morbid obesity: high band failure rate with safe revisions (ID 26)
  Catherine Tsai (Switzerland)
11:30-11:40 O-012 Vertical sleeve gastrectomy or Roux-en-Y Gastric Bypass? A Systems epidemiology approach for bariatrics personalized treatment (ID 173)
  Styliani Geronikolou (Greece)
11:40-11:50 O-013 One Anastomosis Gastric Bypass versus sleeve gastrectomy for morbid obesity: a meta-analysis (ID 90)
  Dimitrios Magouliotis (Greece)
11:50-12:00 O-014 One Anastomosis Gastric Bypass versus Roux-en-Y-Gastric Bypass as primary bariatric procedures: Mid-term results with 622 cases from a single institution (ID 148)
  Karl Peter Rheinwalt (Germany)
12:00-12:10 O-015 Evolution of comorbidities at 1, 2 and 5-years follow up after sleeve gastrectomy, Roux-en-Y Gastric Bypass (RYGB) and One Anastomosis Gastric Bypass (OAGB): A comparative study (ID 179)
  Jaime Ruiz-Tovar (Spain)
12:10-12:20 O-016 Simultaneous conversion of gastric band to sleeve gastrectomy: an analysis of 98,298 patients from the MBSAQIP Database (ID 215)
  Nestor De La Cruz-Munoz (USA)
12:20-12:30 Discussion
   
12:30-14:30 LUNCH BREAK & INDUSTRY SYMPOSIUM
   
  Nikos Skalkotas Hall
14:30-16:00 DEBATE: WHICH BYPASS IS BETTER?
Chairs Philippe Topart, Jerome Dargent, Evangelos Nanos
14:30-14:50 Standard RYGB
  Harry Pappis (Greece)
14:50-15:10 OAGB
  Konstantinos Albanopoulos (Greece)
15:10-15:30 Long biliary limb
  Frits Berends (The Netherlands)
15:30-15:50 Banded bypass
  Edo Aarts (The Netherlands)
15:50-16:00 Discussion
   
  MC2
14:30-16:00 ORAL COMMUNICATIONS: Surgery of Diabetes. A New Era
Chairs Dror Dicker, Marco Bueter, Magdalini Bristianou
14:30-15:00 Why and when to operate on Diabetes
  Scott Shikora (USA)
15:00-15:10 O-017 Standardized peri- and postoperative treatment protocol in insulin dependent type 2 diabetes patients undergoing Roux-en-Y Gastric Bypass surgery (ID 32)
  Laura Deden (The Netherlands)
15:10-15:20 O-018 Have National Institute for Health and Care Excellence (NICE) Guidelines for people with type 2 diabetes and obesity been implemented in the UK? (ID 247)
  Roxanna Zakeri (UK)
15:20-15:30 O-019 Laparoscopic sleeve gastrectomy improves diabetes mellitus in the long term (ID 154)
  Ioannis-Petros Katralis (Greece)
15:30-15:40 O-020 Roux-en-Y Gastric Bypass leads to superior improvements in fasting and postprandial glycemic and lipid profile than sleeve gastrectomy (ID 139)
  Chrysi Koliaki (Greece)
15:40-15:50 O-021 Time to glycemic control -- an observational study of 3 different operations (ID 131)
  Sjaak Powels (The Netherlands)
15:50-16:00 O-022 Metabolic Surgical Outcomes in a United States Appalachian Population (ID 248)
  Makenzie Barr (USA)
   
  MC3
14:30-16:00 ORAL COMMUNICATIONS: Sleeve, RYGB, OAGB,BPD,SADI
Chairs Luigi Angrisani, Alexander Neimark, George Spiliopoulos
14:30-14:40 O-023 Revisional surgery - Change of frequency and type revisional surgery during last 3 decades (ID 130)
  Rudolf Weiner (Germany)
14:40-14:50 O-024 OAGB and its Early Compilations - Data From 921 Consecutive Operations (ID 64)
  Yonatan Lessing (Israel)
14:50-15:00 O-025 Mid- and long-term evolution  of weight loss after sleeve gastrectomy (SG), Roux-en-Y Gastric Bypass (RYGB) and One Anastomosis Gastric Bypass (OAGB): A comparative study (ID 178)
  Jaime Ruiz-Tovar (Spain)
15:00-15:10 O-026 Long-term follow-up of older patients with super obesity and biliopancreatic diversion with duodenal switch (ID 174)
  Philipp C. Nett (Switezrland)
15:10-15:20 O-027 Are there ideal bowel lenghts to obtain optimal weight loss after One Anastomosis Gastric Bypass (OAGB)? (ID 180)
  Jaime Ruiz-Tovar (Spain)
15:20-15:30 O-028 Comparative evaluation of Pylorus-preserving types of Biliopancreatic Diversion (SADI’s vs. Switch) (ID 76)
  Yury Yashkov (Russia)
15:30-15:40 O-029 Weight regain after gastric sleeve operation: our experience with SADI- S Bypass (ID 194)
  Vasiliki Christogianni (Greece)
15:40-15:50 O-030 Safety and Effectiveness of OAGB (ID 22)
  Asnat Raziel (Israel)
15:50-16:00 Discussion
   
16:00-16:30 POSTER SESSION II / COFFEE BREAK / COMMERCIAL EXHIBITION
   
  Nikos Skalkotas Hall
16:30-18:00 REVISIONAL Sleeve Gastrectomy
Chairs Jean-Marc Chevallier, Torsten Olbers, George Tzovaras
16:30-16:45 When to revise and which procedures? - Introduction
  Rachel Batterham (UK)
16:45-17:00 When to revise and which procedures? Reflux / Barrett
  Gerhard Prager (Austria)
17:00-17:15 Sleeve to DS
  Philippe Topart (France)
17:15-17:30 Surgical options - Sleeve to RYGB
  Antonio Iannelli (France)
17:30-17:45 Surgical options - Sleeve to SADI
  Esteban Martin Antona (Spain)
17:45-18:00 Surgical options -  Sleeve to OAGB
  George Skroubis (Greece)
   
  MC2
16:30-18:00 YOUNG IFSO
Chairs Luigi Angrisani, Catalin Copaescu, Vasilis Drakopoulos
16:30-16:45 Treatment algorithm for a failed bypass
  Bruno Dillemans (Belgium)
16:45-16:55 O-031 Low food access ranking among West Virginia Appalachian metabolic surgery patients (ID 249)
  Melissa Olfert (USA)
16:55-17:05 10 years results bypass vs sleeve-results from a patients survey
  Sylvia Weiner (Germany)
17:05-17:15 O-032 Initial experience of endoscopic radiofrequency waves delivery to the lower oesophageal sphincter (Stretta procedure) on symptomatic Gastroesophageal reflux disease post sleeve gastrectomy (ID 82)
  Nesreen Khidir (Quatar)
17:15-17:25 O-033 Side-side jejunoileal anastomosis as a revisional procedure in failed sleeve gastrectomy (ID 203)
  Eren Taskin (Turkey)
17:25-17:35 New bariatric procedures – past or future?
  Aleksandr Neimark (Russia)
17:35-17:45 O-034 Comparative study of medical versus surgical weight loss in elderly: Cardiometabolic and nutritional changes at one year follow up (ID 209)
  Moamena El-Matbouly (Quatar)
17:45-17:55 O-035 The adjustabile gastric bands - is there time to say good bye? (ID 134)
  Karin Dolezalova (Czech Republic)
   
  MC3
16:30-18:00 ORAL COMMUNICATIONS: Metabolic Effects of Surgeries
Chairs Rudolf Weiner, Yuri Yaskhov, Evangelos Menenakos
16:30-16:40 O-036 Gastric bypass specifically alters liver parameters as compared to sleeve gastrectomy, independently of steatosis evolution, one year after surgery (ID 15)
  Séverine Ledoux (France)
16:40-16:50 O-037 Transient elastography for the assessment of NAFLD in bariatric/metabolic patients- a real life setting (ID 157)
  Magdalena Eilenberg (Austria)
16:50-17:00 O-038 Sugar detection threshold after laparoscopic sleeve gastrectomy in adolescents (ID 69)
  Ghalia N. Abdeen (Saudi Arabia)
17:00-17:10 O-039 How often do restrictive bariatric operations cause metabolic deficiencies? (ID 152)
  Ioannis-Petros Katralis (Greece)
17:10-17:20 O-040 Direct measurement of macronutrient intake and preference 1 year after Roux-en-Y Gastric Bypass (RYGB) (ID 238)
  Natasha Kapoor (Ireland)
17:20-17:30 O-041 Impact of gut hormone FGF-19 on type-2 diabetes and mitochondrial recovery in a prospective study of obese diabetic women undergoing bariatric surgery (ID 103)
  Martin Fried (Czech Republic)
17:30-17:40 O-042 Effects of sleeve gastrectomy on the expression and dna methylation of human intermediary metabolism, inflammation and weight control-related genes in whole blood (ID 167)
  Marc Beisani (Spain)
17:40-17:50 O-043 Single Anastomosis Duodenal Ileal bypass with Sleeve Gasterctomy versus Roux-en-Y Gastric Bypass: comparison of results on glycemic homeostasis and weight loss. A murine model (ID 30)
  Laura Montana (France)
17:50-18:00 O-044 Monocyte subpopulations in peripheral blood are suitable for non-invasive diagnosis of NASH in patients with obesity (ID 93)
  Katharina Staufer (Austria)
   
  Nikos Skalkotas Hall
18:00-19:30 OPENING CEREMONY
IFSO-EC PRESENTATION AND AWARDS
Chairs TBA
  Ancient Greek Surgery inspiring Current Practice
  Vassilios Golematis (Greece)

 

Friday, May 18

  Nikos Skalkotas Hall
09:00-10:30 MECHANISMS UNDERLYING BENEFICIAL EFFECTS
Chairs Martin Fried, Sylvia Weiner, Nicholas Katsilambros
09:00-09:30 Gut hormones, enterokines and gut-derived lipid mediators
  Rachel Batterham  (UK)
09:30-09:55 Bile acids; are they the new gut hormones?
  Dimitri Pournaras (UK)
09:55-10:20 Implications of Gut microbiota changes after bariatric surgery
  Nuria Vilarrasa (Spain)
10:20-10:30 Discussion
   
  MC2
09:00-10:30 ORAL COMMUNICATIONS: Miscellaneous I
Chairs Roel Bolckmans, Karin Dolezalova, Konstantinos Milias
09:00-09:10 O-045 Preoperative education and informed consent in young adults undergoing bariatric surgery: patients’ perspectives on current practice (ID 116)
  Danielle Bonouvrie (The Netherlands)
09:10-09:20 O-046 Bariatric surgery and incidental gastrointestinal stromal tumors – a single-center study (ID 169)
  Orestis Lyros (Germany)
09:20-09:30 O-047 Obesity as a determinant of post-operative outcome in patients following colorectal cancer surgery: a population based study (2009-2016) (ID 12)
  Youri Poelemeijer (The Netherlands)
09:30-09:40 O-048 Proven post-op weight maintenance factors and behavioral follow-through using Acceptance Commitment Therapy, Motivational Enhancement Therapy and Dialectical Behavior Therapy techniques by the entire multidisciplinary team (ID 207)
  Connie Stapleton (USA)
09:40-09:50 O-049 Blind loop syndrom after Roux-en-Y Gastric Bypass (ID 46)
  Volker Lange (Germany)
09:50-10:00 O-050 Transitory jejuno-gastric intussesception as a potential cause of epigastric pain and dyspepsia after the gastric bypass surgery (ID 9)
  Yaroslav Isaev (Germany)
10:00-10:10 O-051 Over three years results of hiatal hernia repair with mesh in a single institution (ID 170)
  Angelo Iossa (Italy)
10:10-10:20 O-052 Alcohol And WLS: It’s a problem the multidisciplinary team needs to address! (ID 210)
  Connie Stapleton (USA)
10:20-10:30 Discussion
   
  MC3
09:00-10:30 ORAL COMMUNICATIONS: Revisional Surgeries
Chairs Richard Welbourn, George Skroubis, Eren Taskin
09:00-09:10 O-053 Single Anastomosis Duodenoileal bypass versus Roux-en-Y Gastric Bypass following failed Sleeve Gastrectomy: A Multicenter Cohort study (ID 146)
  Phillip Dijkhorst (The Netherlands)
09:10-09:20 O-054 Conversion of Both Versions of Vertical Banded Gastroplasty to Laparoscopic Roux-en-Y Gastric Bypass, Analysis of Short-term Outcomes (ID 95)
  Talal Khewater (Belgium)
09:20-09:30 O-055 Outcome of revisional bariatric surgery for insufficient weight loss after laparoscopic Roux-en-Y Gastric Bypass (ID 200)
  Katja Allgaier (Switzerland)
09:30-09:40 O-056 Weight regain after vertical gastric plication: Sleeve gastrectomy or Roux-en-Y Gastric Bypass as a salvage procedure? Analysis of the first 300 consecutive patients (ID 100)
  Elie Chouillard (France)
09:40-09:50 O-057 The failed Roux-en-Y Gastric Bypass:  band or distalization? (ID 41)
  Abel Boerboom (The Netherlands)
09:50-10:00 O-058 Revision in 1000 consecutive Patients Who Had Sleeve Gastrectomy for Morbid Obesity in a Single Center (ID 98)
  Elie Chouillard (France)
10:00-10:10 O-059 Outcome and risks of surgical reintervention for weight regain after RYGB (ID 150)
  Daniel Moritz Felsenreich (Austria)
10:10-10:20 O-060  Lack of Uniform Definition of Success, Failure and Weight Regain After Primary Roux-en-Y Gastric Bypass and Gastric Sleeve (ID 104)
  Danielle Bonouvrie (The Netherlands)
10:20-10:30 Discussion
   
10:30-11:00 POSTER SESSION III / COFFEE BREAK / COMMERCIAL EXHIBITION
   
  Nikos Skalkotas Hall
11:00-12:30 EASO/IFSO-EC Joint Session: HOW TO BUILD AN EFFECTIVE AND SAFE CLINICAL PATHWAY FOR BARIATRIC SURGERY PATIENTS
Chairs Luca Busetto, Harry Pappis
11:00-11:20 How to select and prepare a patient for surgery
  Dror Dicker (Israel)
11:20-11:40 How to decide the type of bariatric /metabolic procedure in the individual cases
  Ralph Peterli (Switzerland)
11:40-12:00 How to improve the availability and the safety of bariatric procedures
  Rachel Batterham (UK)
12:00-12:20 How to build an effective long-term follow-up
  Luca Busetto (Italy)
12:20-12:30 Discussion
   
  MC2
11:00-12:30 ORAL COMMUNICATIONS: Sleeve Gastrectomy
Chairs Gerhard Prager, Antonio Iannelli, Dimitrios Lapatsanis
11:00-11:10 O-061 Gastroesophageal reflux disease following LSG: a prospective study (ID 193)
  Viktoria Michalopoulou (Greece)
11:10-11:20 O-062 Incidence of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy with staple line reinforcement with oversewing and staple line inversion vs buttressing material (ID 184)
  Jaime Ruiz-Tovar (Spain)
11:20-11:30 O-063 Pushing the limits in bariatric surgery: sleeve gastrectomy for morbidly obese patients over 65 years old (ID 19)
  Panagiotis Lainas  (France)
11:30-11:40 O-064 Food tolerance and quality of alimentation following laparoscopic sleeve gastrectomy calibrated with a 50-Fr bougie: Long-term results (ID 187)
  Jaime Ruiz-Tovar (Spain)
11:40-11:50 O-065 Preoperative detection of sarcopenic obesity helps to predict the occurrence of gastric leak after sleeve gastrectomy (ID 17)
  Panagiotis Lainas (France)
11:50-12:00 O-066 The comparative analysis of sleeve gastrectomy with and without antrumectomy (ID 37)
  Taryel Omerov (Azerbaijan)
12:00-12:10 O-067 Nine-Year experience with laparoscopic sleevegastrectomy in a tertiary public hospital in Greece (ID 236)
  Angeliki Kolinioti (Greece)
12:10-12:20 O-068 The endoscopic-vacuum assisted closure-technique in the treatment of staple line leaks after sleeve gastrectomy (ID 137)
  Vasiliki Christogianni (Greece)
12:20:12:30 Discussion
   
  MC3
11:00-12:30 ORAL COMMUNICATIONS: Endoluminal & Innovative Procedures, incl. Robotics
Chairs Alberic Fiennes, Marco Bueter, Andreas Alexandrou
11:00-11:20 Robotics in bariatric surgery: My view
  Scott Shikora (USA)
11:20-11:30 O-069 Results of the Crossover Group in the Randomized Controlled Multicenter MILEPOST Study for Primary Obesity (POSE) vs. Diet-Exercise alone (ID 168)
  Karl Miller (Austria)
11:30-11:40 O-070 Reversible gastric bypass with fundectomy and gastric remnant exploration (lrygbfse): results at 5-years follow-up (ID 34)
  Giovanni Lesti (Italy)
11:40-11:50 O-071 Elipse® Swallowable Intragastric  Balloon + Very Low Calorie Ketogenic Diet (VLCKD): A Novel Strategy to Optimize Weight-Loss and Minimize Side Effects (ID 243)
  Roberta Ienca (Italy)
11:50-12:00 O-072 Modified laparoscopic Sleeve Gastrectomy combined with Rossetti fundoplication (R-Sleeve): midterm results after more than 170 procedures (ID 158)
  Matteo Uccelli (Italy)
12:00-12:10 O-073 Magenstrasse and Mill procedure with Nissen-Rossetti fundoplication as an alternative option for bariatric patients with gastroesophageal reflux or hiatal hernia (ID 21)
  Bernard Majerus (Belgium)
12:10-12:20 O-074 Robotic versus conventional laparoscopic minigastric bypass: is innovation always better? (ID 161)
  Hakan Karatas (Turkey)
12:20-12:30 O-075 Effect of the EndoBarrier Device: a 4-year follow up of a multicenter randomized clinical trial (ID 51)
  Yvonne Roebroek (The Netherlands)
   
12:30-14:30 LUNCH BREAK & INDUSTRY SYMPOSIUM
   
  Nikos Skalkotas Hall
14:30-16:00 EASO/IFSO-EC Joint Session: HOW TO TACKLE SPECIFIC BARIATRIC PROBLEMS: CLINICAL CASES
Chairs Theodor K. Alexandrides, Michel Suter
14:30-14:50 Management of extreme obesities
  Gerhard Prager (Austria)
14:50-15:10 Pre and post-operative deficiencies: the reality
  Johanna Brix (Austria)
15:10-15:30 Post bariatric hypoglycaemia: diagnosis and medical solutions
  Andrea Pucci (UK)
15:30-15:50 Abdominal pain after bariatric surgery: prevalence, evaluation, management
  Martin Fried (Czech Republic)
15:50-16:00 General discussion
   
  MC2
14:30-16:00 METABOLIC EFFECTS OF SURGERY: CAN WE DISTINGUISH  BETWEEN PROCEDURES?
Chairs Rachel Batterham, Luca Busetto, Alexander Kokkinos
14:30-15:00 Introductory lecture
  Marco Bueter (Switzerland)
15:00-15:10 O-076 Determination of underlying genetic variations in an obese cohort of more than 1000 patients and the effect of bariatric surgery (ID 68)
  Mellody Cooiman (The Netherlands)
15:10-15:20 O-077 Appetite, glycemia, and entero-insular hormone responses differ between oral, gastric-remnant, and duodenal administration of a mixed meal test after Roux-en-Y Gastric Bypass (ID 10)
  Daniel Gero (Switzerland)
15:20-15:30 O-078 Effects of different metabolic states and surgical models on glucose metabolism and secretion of ileal L-Cell peptides: Results from the HIPER-1 study (ID 132)
  Sjaak Powels (The Netherlands)
15:30-15:40 O-079 Reduction in Iron deficiency after Sleeve gastrectomy in women, a prospective controlled cohort study (ID 177)
  Zoubida Karim (France)
15:40-15:50 O-080 Sleeve gastrectomy: Does the procedure impact gut hormones or the induced weight loss does (ID 113)
  Panagiotis Patrikakos (Greece)
15:50-16:00 O-081 Taste sensitivity to dietary fat before and after bariatric surgery:  A cross-sectional study of oleic acid taste detection thresholds with correlation to GLP-1 profiles (ID 87)
  Janine Makaronidis (UK)
   
  MC3
14:30-16:00 VIDEO SESSION:  Interesting Cases & Conversions
Chairs Esteban Martin Antona, Luigi Angrisani, Konstantinos Albanopoulos
14:30-14:40 V-001 Surgical treatment for Nesidioblastosis after Roux-en-Y Gastric Bypass (ID 23)
  Hadar Nevo (Israel)
14:40-14:50 V-002 Prevention of reflux-esophagitis after laparoscopic sleeve gastrectomy  by creating a three-chambered gastric sleeve (ID 89)
  Olesya Starzhinskaya (Russia)
14:50-15:00 V-003 Early small bowel obstruction after bariatric surgery: strategy for successful laparoscopic management (ID 225)
  Charalampos Markakis (Greece)
15:00-15:10 V-004 Postoperative case:  Unusual case of an upper GI bleeding years after Roux-en-Y Gastric Bypass (ID 221)
  Maria Solovyeva (Russia)
15:10-15:20 V-005 Redo laparoscopic sleeve gastrectomy. Technical aspects to prevent stenosis and late leak subsequent to stomach antrum twisting (ID 256)
  Georgios Ayiomamitis (Greece)
15:20-15:30 V-006 Solution of severe reflux post LSG, post RNY: Toupet “fundoplication” with the remnant sleeve stomach (case report) (ID 252)
  Farah Ibrahim Bakhit Juma (United Arab Emirates)
15:30-15:40 V-007 Laparoscopic repair of giant hiatus hernia and Roux-en-Y Gastric Bypass (ID 159)
  Lydia Eleni Oannidi (UK)
15:40-15:50 V-008 Laparoscopic conversion from vertical banded gastroplasty with hiatal hernia associated to Roux-en-Y Gastric Bypass (ID 159)
  Maria Recarte (Spain)
15:50-16:00 V-009 Laparoscopic conversion of gastric bypass into sleeve gastrectomy (ID 140)
  Romano Schneider (Switzerland)
   
16:00-16:30 POSTER SESSION IV / COFFEE BREAK / COMMERCIAL EXHIBITION
   
  Nikos Skalkotas Hall
16:30-17:30 LONG-TERM TREATMENT OUTCOMES (>10y)
Chairs Ralph Peterli, Odysseas Voudouris
16:30-16:45 Long term results of LAGB
  Stelios Kapiris (Greece)
16:45-17:00 Long term results of SG
  Dimitris Zacharoulis (Greece)
17:00-17:15 Long term results of RYGB
  Michel Suter (Switzerland)
17:15-17:30 Long term results of BPD-DS
  Roel Bolckmans (Belgium)
   
  MC2
16:30-17:30 ORAL COMMUNICATIONS: Miscellaneous II
Chairs Dimitri Pournaras, Karl Miller, Georgios Ayiomamitis
16:30-16:40 O-082 First things first: pregnancy or bariatric surgery? (ID 143)
  Edo Aarts (The Netherlands)
16:40-16:50 O-083 Laparoscopic sleeve gastrectomy for morbidly obese patients under 18 years-old (ID 27)
  Panagiotis Lainas (France)
16:50-17:00 O-084 Bariatric surgery in the elderly: is sleeve gastrectomy a feasible option (ID 153)
  Athanasios Pantelis (Greece)
17:00-17:10 O-085 Weight loss, Reduction of Comorbidities and Quality of Life after Bariatric Surgery in the Elderly (ID 52)
  Mellody Cooiman (The Netherlands)
17:10-17:20 O-086 Multi-centre, intraoperative micro-costing of Roux-en-Y Gastric Bypass, adjustable gastric banding and sleeve gastrectomy procedures for the treatment of severe, complex obesity in the United Kingdom (ID 39)
  Brett Doble (UK)
17:20-17:30 O-087 Association between cardiorespiratory fitness and excess weight loss after sleeve gastrectomy (ID 181)
  Paulina Ibacache (Chile)
   
  MC3
16:30-17:00 VIDEO SESSION: Redo Cases
Chairs David Nocca, Fausta Micanti, Emmanuel Leandros
16:30-16:40 V-010 Re-sleeve with silastic ring and crurorhaphy in a rare case of severe hyperinsulimic hypoglycemia after sleeve gastrectomy (ID 53)
  Catherine Tsai (Switzerland)
16:40-16:50 V-011 Laparoscopic Reversal of Roux-en-Y Gastric Bypass (LRYGB) (ID 29)
  Ron Dar (Israel)
16:50-17:00 V-012 Failed sleeve gastrectomy: 3 surgical proposals (ID 176)
  Konstantinos Albanopoulos (Greece)
17:00-17:10 V-013 Gastric bypass as conversion from abandoned bariatric procedures: gastric plication, banding or pacemaker, toga or banded vertical gastroplasty.  A video remix (ID 171)
  Cristian Boru (Italy)
17:10-17:20 V-015 Salvation gastric bypass as conversion from failed, open banded vertical gastroplasty (ID 246)
  Cristian Boru (Italy)
17:20-17:30 Discussion
   
17:30-18:30 General Council
   
20:00 Farewell Event

 

Saturday, May 19

  Nikos Skalkotas Hall
09:00-11:00 DEBATE: Band, Sleeve or Bypass
Chairs Antonio Torres, Maurizio De Luca, Stelios Kapiris
09:00-09:20 SLEEVEPASS
  Paulina Salminen (Finland)
09:20-09:40 SM-BOSS
  Ralph Peterli (Switzerland)
09:40-10:00 Evidence for Sleeve
  David Nocca (France)
10:00-10:20 Evidence for bypass
  Catalin Copaescu (Romania)
10:20-10:40 Roux-en-Y or One Anastomosis Gastric Bypass
  John Melissas (Greece)
10:40-11:00 What is the current place (if any) for gastric banding?
  Jean-Marc Chevallier (France)
   
  MC2
09:00-10:40 ORAL COMMUNICATIONS: Integrated Health
Chairs Luigi Angrisani, Frits Berends, Christos Zoupas
09:00-09:10 O-088 Taste makes waist? The relationship between energy intake and weight loss in Dutch bariatric patients (ID 50)
  Laura Deden (The Netherlands)
09:10-09:20 O-089 Determination of slimming effect by auricular Acupuncture stimulation -Statistical analysis of 1500 female data (ID 35)
  Takahiro Fujimoto (Japan)
09:20-09:30 O-090 Serum uromodulin in diabetic nephropathy (ID 160
  Katharina Scheurlen (Germany)
09:30-09:40 O-091 Histopathology Findings in Patients Undergoing Laparoscopic Sleeve Gastrectomy (ID 165)
  Angelo Iossa (Italy)
09:40-09:50 O-092 Bariatric surgery for people with intellectual disability (ID 5)
  Julia Hilbert (Germany)
09:50-10:00 O-093 The effect of bariatric surgery on direct oral anticoagulant activity of rivaroxaban after bariatric surgery: the extension study (ID 164)
  Dino Kröll (Switzerland)
10:00-10:10 O-094 Multipurposed Abdominoplasty after bariatric surgery (ID 75)
  Yury Yashkov (Russia)
10:10-10:20 O-095 The Effects of Protein-Riched Diet, Performed Before Bariatric Surgery, On Losing Weight, Clinical Results And Liver Volume Reduction (ID 245)
  Nihal Zekiye Erdem (Turkey)
10:20-10:30 O-096 A structured approach to airway management in the morbidly obese patient: the experience of a high volume bariatric center at Humanitas Research Hospital (Italy) (ID 54)
  Chiara Ferrari (Italy)
10:30-10:40 Discussion
   
  MC3
09:00-10:40 ORAL COMMUNICATIONS: Multidisciplinary
Chairs Marco Bueter, Efthimios Kapantais
09:00-09:10 O-097 The effect of pre-surgery information online lecture on nutrition-knowledge and anxiety among bariatric surgery candidates (ID 20)
  Shiri Sherf-Dagan (Israel)
09:10-09:20 O-098 Attendance of follow-up visits after bariatric  operation within 5 years (ID 45)
  Anke Rosenthal (Germany)
09:20-09:30 O-099 Interpersonal characters among bariatric candidates compared to control group (ID 117)
  Inbal Globus (Israel)
09:30-09:40 O-100 How to treat iron deficiencies after RYGB: outcomes of an RCT (ID 213)
  Edo Aarts (The Netherlands)
09:40-09:50 O-101 Vitamin, trace element and protein status of patients undergoing Single Anastomosis Gastric Bypass (ID 191)
  Julia Jedamzik (Austria)
09:50-10:00 O-102 Metabolic Surgeons self-assessing sexual health issues in disease management of morbid obese patients at the Austrian Congress of Surgeons, June 2017 (ID 228)
  Lucia Ucsnik (Austria)
10:00-10:10 O-103 Do specialized bariatric multivitamins lower deficiencies after RYGB? (ID 142)
  Edo Aarts (The Netherlands)
10:10-10:20 O-104 Effects of preoperative  nutritional supplements enriched with Omega-3 fatty acids on postoperative pain and analytical acute-phase reactants in  patients undergoing Roux-en-Y Gastric Bypass (ID 196)
  Jaime Ruiz-Tovar (Spain)
10:20-10:30 O-105 Nutritional management of bariatric surgery patients in order to attenuate bone deterioration (ID 3)
  Tair Ben-Porat (Israel)
10:30-10:40 Discussion
   
11:00-11:30 COFFEE BREAK
   
  Nikos Skalkotas Hall
11:30-13:00 METABOLIC SURGERY FOR T2DM BMI < 35
Chairs Michel Suter, Gerhard Prager, Harry Pappis
11:30-11:50 Overview of the evidence
  Marco Bueter (Switzerland)
11:50-12:10 Experience in Israel
  Nasser Sakran (Israel)
12:10-12:30 Experience in the UK
  Richard Welbourn (UK)
12:30-12:50 Experience in Italy
  Luigi Angrisani (Italy)
12:50-13:00 Round table discussion
   
  MC2
11:30-13:00 BEST ABSTRACT SESSION
Chairs Alberic Fiennes, Ralph Peterli, Rachel Batterham
11:30-11:40 O-106 The impact of Roux-en-Y Gastric Bypass on bone remodelling expressed by the P1NP/βCTX ratio: a single-center prospective cohort study (ID 43)
  Daniel Gero (Switzerland)
11:40-11:50 O-107 Beta cells in patients with changes in glycemic control after Roux-en-Y Gastric Bypass surgery, visualized by 68Ga-exendin-4 PET/CT (ID 16)
  Laura Deden (The Netherlands)
11:50-12:00 O-108 Features of oral glucose tolerance test in patients with and without late dumping after Roux-en-Y Gastric Bypass: it’s all about speed (ID 77)
  Ilke Marien (Belgium)
12:00-12:10 O-109 Dumping syndrome after gastric bypass: endoluminal revision of the dilated gastrojejunostomy is a safe and highly effective treatment option (ID 25)
  Catherine Tsai (Switzerland)
12:10-12:20 O-110 Impact of implementation of an Enhanced Recovery After Surgery (ERAS) program in in laparoscopic Roux-en-Y Gastric Bypass: A prospective randomized clinical trial (ID 183)
  Jaime Ruiz-Tovar (Spain)
12:20-12:30 O-111 Gastro-esophageal reflux disease one year after One Anastomosis Gastric Bypass (ID 190)
  Viktoria Michalopoulou (Greece)
12:30-12:40 O-112 Long-term weight loss after Roux-en-Y Gastric Bypass is independant from age at baseline (ID 114)
  Styliani Mantziari (Switzerland)
12:40-12:50 O-113 Band and Extend? Results of 2 randomized controlled trials on RYGB improvement (ID 42)
  Abel Boerboom (The Netherlands)
12:50-13:00 O-114 Procalcitonin (PCT) as a marker of postoperative complications in bariatric surgery. A prospective study (ID 73)
  Laura Montana (France)
   
  MC3
11:30-13:00 ORAL COMMUNICATIONS: Allied Health
Chairs Jean-Marc Chevallier, Martin Fried, Maria Giannakoulia
11:30-11:40 O-115 Pre-operative Very Low Calory Ketogenic Diet (VLCKD) vs. Very Low Calory Diet (VLCD): Surgical impact (ID 260)
  Alice Albanese (Italy)
11:40-11:50 O-116 The influence of body weight on brain function and structure. The BARICO study: study rationale and protocol (ID 38)
  Debby Vreeken (The Netherlands)
11:50-12:00 O-117 Obstructive sleep apnea in obese patients; postoperative outcomes of postoperative pulse oximetry without preoperative OSA screening (ID 133)
  Sophie L. van Veldhuisen (The Netherlands)
12:00-12:10 O-118 Self-efficacy in weight management, patient satisfaction and lifestyle habits after standard gastric bypass (ID 119)
  Alexia Katsarou (Greece)
12:10-12:20 O-119 Comparison of nutritional status and neonatal outcomes in pregnant women after Roux-en-Y Gastric Bypass and sleeve gastrectomy (ID 14)
  Muriel Coupaye (France)
12:20-12:30 O-120 Nutritional status of vegetarian candidates for laparoscopic sleeve gastrectomy (ID 2)
  Shiri Sherf-Dagan (Israel)
12:30-12:40 O-121 The role of adjuvant pharmacotherapy in the management of patients with a partial response to bariatric metabolic surgery-the first Australian experience (ID 233)
  Georgia Rigas (Australia)
12:40-12:50 O-122 Bariatric surgery as a salvage operation in critically ill/septic superobese patients - an option? (IS 81)
  Kamil Yamac (Germany)
12:50-13:00 O-123 Analgesic effect of laparoscopic-guided Transversus Abdominis Plane blockade vs Port-site infiltration as analgesic multimodal approach after Roux-en-Y Gastric Bypass: A prospective randomized study (ID 189)
  Jaime Ruiz-Tovar (Spain)
   
13:00-13:30 Closing Ceremony
   

 

CONGRESS SECRETARIAT
GUARANT International spol. s r. o.
Na Pankráci 17, 140 21  Prague 4
Czech Republic

Phone: +420 284 001 444, Fax: +420 284 001 448
E-mail: ifso-ec2018@guarant.cz





© 2017 GUARANT International spol. s r. o.